feed,title,long_url,short_url
Barron's,FDA Advisory Panel Says Risks Outweigh Benefits of Pfizer and Lilly's Pain Drug,https://www.barrons.com/articles/fda-advisory-panel-says-risks-outweigh-benefits-of-pfizer-and-lillys-pain-drug-51616760826?mod=RTA,https://j.mp/3ffwdBA
